InvestorsHub Logo

MinnieM

03/02/21 10:35 AM

#349871 RE: stevo99 #349822

It depends on whether or not they are looking for longer term disease.

Brialacidin has multiple MOA and that may take longer to analyze. Too many variables to guess on how long this will actually take.

I'm just happy the Brilacidin covid trials have finally started.





Message in reply to:

I'd like to know why Leo wasn't able to negotiate a shorter follow up. Remdesivir was 11 days and we're at 29?! Seems to me we should know if B is working within less than 11 days.